Skip to main content
WorldVoice 360
HealthUnited States

John Green Discusses the Harsh Realities of Tuberculosis in New Book

Best-selling author sheds light on the past, present, and future of TB in conversation with The Times.

By Stephanie NolenSource: nytimes.com1 min read
John Green Discusses the Harsh Realities of Tuberculosis in New Book
Image via nytimes.com

In brief

In an engaging discussion, John Green highlights the key aspects of tuberculosis and its ongoing challenges through his latest work.

On March 27, 2025, global health reporter Stephanie Nolen sat down with renowned young adult novelist John Green, whose profound influence has reached millions through his intriguing storytelling. Known for his emotionally charged narratives, Green's new venture takes a significant turn into nonfiction as he delves deeply into the subject of tuberculosis (TB) in his book "Everything is Tuberculosis: The History and Persistence of Our Deadliest Infection."The inspiration for his latest work lies in his fascination with TB, a disease that remains a pressing issue despite being fully curable. Green's exploration shows how TB's historical influence has permeated various aspects of culture, even shaping events like New Mexico's statehood. The alarming statistic of 1.3 million deaths attributed to TB in the preceding year prompts critical questions about global health efforts and the sustainability of progress made in combatting this disease.However, Green expresses concern as recent national policy changes have jeopardized international health initiatives. The abrupt dismantlement of the U.S. Agency for International Development by the Trump administration has resulted in diminished support for essential health programs globally, undermining the fight against TB and other infectious diseases. Green's dialogue with Nolen underscores the pressing need to address vaccine accessibility and expansive discussions around TB. Sharing this message across social platforms, he has mobilized his audience to advocate for drug manufacturers to lower prices for crucial TB medication.For those interested in hearing the full conversation featuring Nolen and Green’s insights on tuberculosis, a recorded interview is available through The New York Times, offering a compelling examination of this crucial topic and the challenges ahead.

Topics

More on this story